Cargando…

Multicenter Validation Study of a Transplantation-Specific Cytogenetics Grouping Scheme for Patients with Myelodysplastic Syndromes

Cytogenetics are an important prognostic factor for patients with MDS. However, existing cytogenetics grouping schemes are based on patients treated with supportive care, and may not be optimal for patients undergoing allogeneic stem cell transplantation (SCT). We previously proposed an SCT-specific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Armand, Philippe, Deeg, H. Joachim, Kim, Haesook T., Lee, Hun, Armistead, Paul, de Lima, Marcos, Gupta, Vikas, Soiffer, Robert J.
Formato:	Texto
Lenguaje:	English
Publicado:	2009
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868955/ https://www.ncbi.nlm.nih.gov/pubmed/19784076 http://dx.doi.org/10.1038/bmt.2009.253

Ejemplares similares

Cytogenetic features in myelodysplastic syndromes
por: Haase, Detlef
Publicado: (2008)

Rare Cytogenetic Abnormalities in Myelodysplastic Syndromes
por: Bacher, Ulrike, et al.
Publicado: (2015)

Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview
por: Zahid, Mohammad Faizan, et al.
Publicado: (2017)

Fit Older Adults with Advanced Myelodysplastic Syndromes: Who is Most Likely to Benefit from Transplant?
por: Abel, Gregory A., et al.
Publicado: (2020)

Cytogenetic features in primary myelodysplastic syndrome Egyptian patients
por: Elnahass, Yasser, et al.
Publicado: (2018)

Chromosomal instability correlates with poor outcome in patients with myelodysplastic syndromes irrespectively of the cytogenetic risk group
por: Heilig, Christoph E, et al.
Publicado: (2010)

Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome and Concurrent Lymphoid Malignancy
por: Zimmerman, Zachary, et al.
Publicado: (2011)

Cytogenetic profile of Indian patients with de novo myelodysplastic syndromes
por: Chaubey, Rekha, et al.
Publicado: (2011)

Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?
por: Saumell, Sílvia, et al.
Publicado: (2015)

Clinicohematological and cytogenetic profile of myelodysplastic syndromes in Pakistan-compare and contrast
por: Anwar, Nida, et al.
Publicado: (2017)

Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA
por: Garcia-Gisbert, Nieves, et al.
Publicado: (2022)

Cytogenetic characteristics in Vietnamese patients diagnosed with primary myelodysplastic syndromes()
por: Vu, Minh Phuong, et al.
Publicado: (2022)

Venous thromboembolism is associated with graft-versus-host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantation
por: Kekre, Natasha, et al.
Publicado: (2017)

The evaluation of the outcome in myelodysplastic patients by using non-cytogenetic prognostic scores
por: Căzăceanu, O, et al.
Publicado: (2014)

Myelodysplastic syndromes: advantages of a combined cytogenetic and molecular diagnostic workup
por: Ciabatti, Elena, et al.
Publicado: (2017)

Myelodysplastic Syndrome in Pakistan: Clinicohematological Characteristics, Cytogenetic Profile, and Risk Stratification
por: Mahmood, Rafia, et al.
Publicado: (2018)

Severe Eosinophilia in Myelodysplastic Syndrome With a Defined and Rare Cytogenetic Abnormality
por: Rai, Shinya, et al.
Publicado: (2019)

PB1996: CYTOGENETIC FEATURES OF 164 MOROCCAN PATIENTS WITH MYELODYSPLASTIC SYNDROME
por: Aghoutane, Yossra, et al.
Publicado: (2023)

Cytogenetic as an Important Tool for Diagnosis and Prognosis for Patients with Hypocellular Primary Myelodysplastic Syndrome
por: Corrêa de Souza, Daiane, et al.
Publicado: (2014)

Phenotypic and Cytogenetic Characterization of Mesenchymal Stromal Cells in De Novo Myelodysplastic Syndromes
por: Rathnayake, A. J. I. S., et al.
Publicado: (2016)

Prognostic landscape of mitochondrial genome in myelodysplastic syndrome after stem-cell transplantation
por: Dong, Jing, et al.
Publicado: (2023)

Long-Term Follow-up of Reduced Intensity Allogeneic Stem Cell Transplantation for Chronic Lymphocytic Leukemia: Prognostic Model to Predict Outcome
por: Brown, Jennifer R., et al.
Publicado: (2012)

Clinical, hematological, and cytogenetic profile of adult myelodysplastic syndrome in a tertiary care center
por: Narayanan, Santhosh
Publicado: (2017)

Cytogenetic characteristics of 665 patients with myelodysplastic syndrome in China: A single-center report
por: Wang, Xueying, et al.
Publicado: (2021)

Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes
por: Yan, Xuefen, et al.
Publicado: (2021)

PB1914: CYTOGENETIC FINDINGS IN 18 CHILDREN WITH MYELODYSPLASTIC SYNDROMES BY KARYOTYPIC AND FISH ANALYSIS
por: Manola, K., et al.
Publicado: (2022)

Impact of clinical, cytogenetic, and molecular profiles on long-term survival after transplantation in patients with chronic myelomonocytic leukemia
por: Woo, Janghee, et al.
Publicado: (2020)

Randomized Study of enterade(®) to Reduce Diarrhea in Patients Receiving High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation
por: De Filipp, Zachariah, et al.
Publicado: (2021)

Cytogenetic study in therapy-related myelodysplastic syndromes (t-MDS) and acute non-lymphocytic leukaemia (t-ANLL).
por: Sozzi, G., et al.
Publicado: (1990)

Accurate Detection of Uniparental Disomy and Microdeletions by SNP Array Analysis in Myelodysplastic Syndromes with Normal Cytogenetics
por: Heinrichs, Stefan, et al.
Publicado: (2009)

Hematologic and Cytogenetic Findings in Myelodysplastic Syndromes Treated with Recombinant Human Granulocyte Colony‐stimulating Factor
por: Ohyashiki, Kazuma, et al.
Publicado: (1989)

3D Telomere Structure Analysis to Detect Genomic Instability and Cytogenetic Evolution in Myelodysplastic Syndromes
por: Rangel-Pozzo, Aline, et al.
Publicado: (2019)

Relapsed Waldenstrom’s Macroglobulinemia and Therapy-Related Myelodysplastic Syndrome with Complex Cytogenetics: A Treatment Dilemma
por: Kalantri, Shreyas, et al.
Publicado: (2023)

FOXP1 and TP63 involvement in the progression of myelodysplastic syndrome with 5q- and additional cytogenetic abnormalities
por: L’Abbate, Alberto, et al.
Publicado: (2014)

Cytogenetic studies of Brazilian pediatric myelodysplastic syndrome cases: challenges and difficulties in a large and emerging country
por: Velloso, E.D.R.P., et al.
Publicado: (2013)

Multiple cytogenetics forms of KMT2A amplification and jumping translocation in a case of myelodysplastic syndrome
por: Ittel, Antoine, et al.
Publicado: (2021)

Clinical and Cytogenetic Characterization of Early and Late Relapses in Patients Allografted for Myeloid Neoplasms with a Myelodysplastic Component
por: Platte, Victoria, et al.
Publicado: (2022)

Clinical, Hematological, and Cytogenetic Profile of Myelodysplastic Syndromes in Adults: A Three-year Cross-sectional Study
por: Abraham, Latha, et al.
Publicado: (2023)

PB2027: EFFICACY OF THERAPY IN PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROME WITH UNFAVORABLE IMMUNOPHENOTYPIC AND CYTOGENETIC PROGNOSIS.
por: Trubkina, Hanna, et al.
Publicado: (2023)

Whole-genome sequencing identifies novel predictors for hematopoietic cell transplant outcomes for patients with myelodysplastic syndrome: a CIBMTR study
por: Zhang, Tao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i6k075kvoq1ka2ooaad6gpamnj